Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
The American Journal of Gastroenterology|July 16, 1999
Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazoleT Havelund, T Lind, I Wiklund, et al.
Health Education Quarterly|January 1, 1994
CATCH: classroom process evaluation in a multicenter trialE W Edmundson, S C Luton, S A McGraw, et al.
Gut|September 18, 2001
The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgeryH E Myrvold, L Lundell, P Miettinen, et al.
European Journal of Gastroenterology & Hepatology|August 25, 2000
Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. The Nordic GORD Study GroupL Lundell, P Miettinen, H E Myrvold, et al.
Transplantation Proceedings|April 1, 1988
Cyclosporine pharmacokinetics in pancreas transplant recipientsR Munda, T J Schroeder, S A Pedersen, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 1998
The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiencyA Juul, S Møller, E Mosfeldt-Laursen, et al.
Oncogene|April 19, 2011
Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic responseY-H Lee, A D Judge, D Seo, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 17, 2017
Differential effects of FXR or TGR5 activation in cholangiocarcinoma progressionO Erice, I Labiano, A Arbelaiz, et al.
Oncogene|July 25, 2012
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomasP Wang, Q Dong, C Zhang, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Pageof 20